đŹ Current Disease Focus:
Task Progress: 0%
đĽ Active Problem Solvers
0
đ Experts collaborating globally
⥠Current Task Assignment
𧏠Genetic Analysis
đ Matching experts to specific tasks
đ Resource Allocation by Research Phase:
đ Data Analysis
𧪠Experimental Design
đŹ Clinical Trials
đ Treatment Development
REP 2139-Ca is nucleic acid polymer. Nucleic acid polymers have been previo...
Status
Completed
Location
Infectious Clinical Hospital ( n.a. Toma Ciorba)
Start Date
2014-09
Trial ID
NCT02233075
Treatments Being Tested
The purpose of this study is to test the safety, tolerability, and efficacy...
Status
Completed
Location
Multiple Locations
Start Date
2009-03-27
Trial ID
NCT00704405
Treatments Being Tested
The primary purpose of this study is to compare the efficacy of two bocepre...
Status
Completed
Location
Multiple Locations
Start Date
2012-05-30
Trial ID
NCT01544920
Treatments Being Tested
This study was to assess the safety and efficacy of sofosbuvir (GS-7977; PS...
Status
Completed
Location
University of Alabama at Birmingham
Start Date
2011-12
Trial ID
NCT01497366
Treatments Being Tested
This study will provide vaniprevir 600 mg or 300 mg twice daily in combinat...
Status
Completed
Location
Multiple Locations
Start Date
2009-10-23
Trial ID
NCT00943761
Treatments Being Tested
This study is being done to compare the safety and efficacy of PEG-Intron⢠...
Status
Terminated
Location
Multiple Locations
Start Date
2012-11-26
Trial ID
NCT01641926
Treatments Being Tested
This is an open-label, randomized, safety, tolerability, dose-finding, PK/P...
Status
Completed
Location
Multiple Locations
Start Date
2011-06-23
Trial ID
NCT01194037
Treatments Being Tested